Trial Profile
Assessment of the Immunogenicity and Safety of PENTAXIM in Philippines.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2013
Price :
$35
*
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Hepatitis B vaccine recombinant
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 22 Apr 2008 Status changed from in progress to completed, according to clinicaltrials.gov.
- 17 Dec 2005 New trial record.